

Name | Size/Type | Description | Date |
---|---|---|---|
AIDA consent | 112KB PDF | AIDA consent | 21 Apr 2020 |
Arsenic with Tretinoin consent | 112KB PDF | Arsenic with Tretinoin consent | 21 Apr 2020 |
Azacitidine + Venetoclax consent | 116KB PDF | Azacitidine and Venetoclax consent | 05 Aug 2024 |
Azacitidine consent | 112KB PDF | Azacitidine consent | 21 Apr 2020 |
Cytarabine subcut consent | 111KB PDF | Cytarabine subcut consent | 21 Apr 2020 |
DA consent | 112KB PDF | DA consent | 21 Apr 2020 |
FLAG+-Ida consent | 113KB PDF | FLAG+-Ida consent | 21 Apr 2020 |
Gilteritinib consent | 111KB PDF | Gilteritinib consent | 31 Jul 2020 |
High dose Cytarabine consent | 112KB PDF | High dose Cytarabine consent | 21 Apr 2020 |
Lenalidomide for MDS consent | 111KB PDF | Lenalidomide consent | 05 Jun 2020 |
MIDAC consent | 112KB PDF | MIDAC consent | 21 Apr 2020 |
Midostaurin consent | 111KB PDF | Midostaurin consent | 21 Apr 2020 |
Mylotarg consent | 113KB PDF | Mylotarg consent | 21 Apr 2020 |
Tretinoin consent | 110KB PDF | Tretinoin consent | 21 Apr 2020 |
Vyxeos consent | 114KB PDF | Vyxeos consent | 21 Apr 2020 |
All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information. You may wish to take your own legal advice before using any of the consent forms.
Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.
These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.
The relevant Macmillan/CRUK leaflet(s) should also be provided to each patient before consent. In no way, however, should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.